CDIB Capital, an overseas investment arm of CDF, specializes in Asian private equity, private debt, and special situations investments.
Location
Rhode Island, US
Founded
2006
CDIB Capital is a leading Asia-based investment firm focused on delivering superior private equity returns. The firm specializes in Asian private equity, private debt, and special situations investments, strategically backing high-growth companies positioned to benefit from China's long-term secular growth. CDIB Capital typically invests in Series A and Series B rounds, with investments ranging from $12 million to $47 million.
As the overseas investment arm of China Development Financial, CDIB Capital partners with high-quality entrepreneurs and management teams to drive shareholder value in the Asia-Pacific region. The firm's portfolio includes notable companies such as Acepodia, Clobotics, and Kneron. CDIB Capital's team of investment professionals brings extensive industry expertise and deep local knowledge to support their portfolio companies' growth and expansion.
Cdib Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies8
Current Portfolio Count8
Top Investment Stages
Series B5 (62.5%)
Series A1 (12.5%)
Series C1 (12.5%)
Series D1 (12.5%)
Stage Mix
Series B 63%Series A 13%Series C 13%Series D 13%
Concentration shown as share of disclosed investments by stage.
